Literature DB >> 11164161

Practice patterns in the diagnosis and treatment of erectile dysfunction among family practice physicians.

S D Rutchik1, M Baudiere, M Wade, G Sullivan, W Rayford, J Goodman.   

Abstract

OBJECTIVES: To examine the philosophies and practices of the family practitioner (FP) regarding the diagnosis and treatment of erectile dysfunction (ED).
METHODS: A prospective study by questionnaire of a group of FPs was performed. The Spearman correlation coefficient and proportional odds regression analysis were used to measure the relationship between the continuous variable and ordinal-scale variables. The Goodman-Kruskal gamma test was used to measure the strength of the association between the ordinal-scale variables.
RESULTS: Eighty-five FPs completed the questionnaire. All respondents had at least occasional discussions with their patients about ED. History taking, physical examination, and laboratory data were the most common tools used for diagnosis. Eighty-two percent of the FPs reported being either comfortable or somewhat comfortable in making a diagnosis of ED; 93% believed that only selected patients required more extensive diagnostic workups for ED. Sildenafil was the most commonly used agent. All physicians referred patients with ED to urologists at least occasionally. Most referred only after unsuccessful trials with sildenafil. The relationship between the degree of managed care penetration and the percentage of patients with ED referred for evaluation to a urologist was not statistically significant (P = 0.402). The relationship between the number of years in practice and the percentage of patients referred to a urologist for treatment or evaluation was found to be a negative, but statistically significant, relationship (P = 0.003).
CONCLUSIONS: FPs are now diagnosing and treating ED on a routine basis. Referrals to urologists are likely to be made when they are no longer comfortable treating the problem.

Entities:  

Mesh:

Year:  2001        PMID: 11164161     DOI: 10.1016/s0090-4295(00)00880-3

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  2 in total

1.  Analysis of prescriptions of alpha-blockers and phosphodiesterase 5 inhibitors from the urology department and other departments.

Authors:  Dong Hyuk Kang; Joo Yong Lee; Jae Hoon Chung; Hee Ju Cho; Jeong Man Cho; Hong Sang Moon; Yong Tae Kim; Tag Keun Yoo; Hong Yong Choi; Hae Young Park; Seung Wook Lee
Journal:  Int Neurourol J       Date:  2011-12-31       Impact factor: 2.835

2.  Treatment Strategy for Non-Responders to PDE5 Inhibitors.

Authors:  Nam Cheol Park; Tae Nam Kim; Hyun Jun Park
Journal:  World J Mens Health       Date:  2013-04-23       Impact factor: 5.400

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.